HRP20160743T1 - Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca - Google Patents
Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca Download PDFInfo
- Publication number
- HRP20160743T1 HRP20160743T1 HRP20160743TT HRP20160743T HRP20160743T1 HR P20160743 T1 HRP20160743 T1 HR P20160743T1 HR P20160743T T HRP20160743T T HR P20160743TT HR P20160743 T HRP20160743 T HR P20160743T HR P20160743 T1 HRP20160743 T1 HR P20160743T1
- Authority
- HR
- Croatia
- Prior art keywords
- analgesia
- local
- collagen
- medicinal substance
- local anesthesia
- Prior art date
Links
- 230000036592 analgesia Effects 0.000 title claims 16
- 210000005036 nerve Anatomy 0.000 title claims 12
- 238000002690 local anesthesia Methods 0.000 title claims 11
- 238000012377 drug delivery Methods 0.000 title claims 5
- 239000012907 medicinal substance Substances 0.000 claims 8
- 239000000515 collagen sponge Substances 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 241000282412 Homo Species 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000011159 matrix material Substances 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 102000012422 Collagen Type I Human genes 0.000 claims 2
- 108010022452 Collagen Type I Proteins 0.000 claims 2
- 230000003187 abdominal effect Effects 0.000 claims 2
- 229960001050 bupivacaine hydrochloride Drugs 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 229940096422 collagen type i Drugs 0.000 claims 2
- 102000013373 fibrillar collagen Human genes 0.000 claims 2
- 108060002894 fibrillar collagen Proteins 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- JCQBWMAWTUBARI-UHFFFAOYSA-N tert-butyl 3-ethenylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(C=C)C1 JCQBWMAWTUBARI-UHFFFAOYSA-N 0.000 claims 2
- 210000000115 thoracic cavity Anatomy 0.000 claims 2
- 230000001988 toxicity Effects 0.000 claims 2
- 231100000419 toxicity Toxicity 0.000 claims 2
- 206010002091 Anaesthesia Diseases 0.000 claims 1
- 238000011538 abdominal hysterectomy Methods 0.000 claims 1
- 230000037005 anaesthesia Effects 0.000 claims 1
- 238000002350 laparotomy Methods 0.000 claims 1
- 230000000399 orthopedic effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Claims (14)
1. Naprava za dopremu lijeka pogodna za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca na određenom mjestu kod potrebitog čovjeka ili životinje, naprava obuhvaća matricu od fibrilarnog kolagena; i barem jednu ljekovitu tvar, najmanje jedna ljekovita tvar je sadržajno homogeno raspršena u matrici kolagena, i najmanje jedna ljekovita tvar je prisutna u količini dovoljnoj za omogućavanje djelovanja lokalne analgezije, lokalne anestezije ili blokade živca u trajanju od najmanje jednog dana nakon primjene pri čemu naprava za primjenu lijeka sadrži množinu spužava kolagena, svaka spužva kolagena ima 3.6 do 8 mg/cm3 kolagena tipa I i 2.0 do 6.0 mg/cm3 bupivakain hidroklorida.
2. Naprava za dopremu lijeka iz patentnog zahtjeva 1, pri čemu je najmanje jedna ljekovita tvar prisutna u količini dovoljnoj za omogućavanje djelovanja lokalne analgezije, lokalne anestezije ili blokade živca u trajanju od najmanje dva dana nakon primjene.
3. Naprava za dopremu lijeka iz patentnog zahtjeva 1ili 2, pri čemu je najmanje jedna ljekovita tvar prisutna u količini dovoljnoj za omogućavanje djelovanja lokalne analgezije, lokalne anestezije ili blokade živca u trajanju od najmanje tri dana nakon primjene.
4. Naprava iz patentnih zahtjeva 1-3, pri čemu je analgezija omogućena bez nuspojava povezanih s toksičnosti bupivakain-kolagen spužve.
5. Naprava iz patentnih zahtjeva 1-4, pri čemu naprava umanjuje pacijentovu potrebu za sustavnom analgezijom.
6. Uporaba naprave za dopremu lijeka koja sadrži matricu od fibrilarnog kolagena; i barem jednu ljekovitu tvar, najmanje jedna ljekovita tvar je sadržajno homogeno raspršena u matrici kolagena, i najmanje jedna ljekovita tvar je prisutna u količini dovoljnoj za omogućavanje djelovanja lokalne analgezije, lokalne anestezije ili blokade živca u trajanju od najmanje jednog dana nakon primjene za proizvodnju lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca kod potrebitog čovjeka ili životinje, analgezija, anestezija ili blokada živca obuhvaća davanje lijeka na određeno mjesto kod potrebitog čovjeka ili životinje pri čemu naprava za primjenu lijeka sadrži množinu spužava kolagena, svaka spužva kolagena ima 3.6 do 8 mg/cm3 kolagena tipa I i 2.0 do 6.0 mg/cm3 bupivakain hidroklorida.
7. Uporaba u skladu s patentnim zahtjevom 6, pri čemu se barem jedna spužva postavlja pored mjesta operativnog zahvata, barem se jedna spužva postavlja preko reza u stijenku tjelesne šupljine i barem se jedna spužva postavlja između obloge i kože oko reza.
8. Uporaba u skladu s patentnim zahtjevom 7, pri čemu je uporaba za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca kod čovjeka nakon laparotomije.
9. Uporaba u skladu s patentnim zahtjevima 7-8, pri čemu je uporaba za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca kod čovjeka nakon ortopedskog, abdominalnog, ginekološkog ili torakalnog operativnog zahvata.
10. Uporaba u skladu s patentnim zahtjevom 9, pri čemu je uporaba za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca kod čovjeka nakon benignih abdominalnih ili torakalnih kirurških zahvata.
11. Uporaba u skladu s patentnim zahtjevom 10, pri čemu je uporaba za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca kod čovjeka nakon abdominalne histerektomije, miomektomije i kirurgije adneksa.
12. Naprava iz patentnih zahtjeva 1-5 ili uporaba iz patentnih zahtjeva 6-11 pri čemu spužve imaju dubinu od 0.5 cm.
13. Uporaba iz patentnih zahtjeva 6-11 pri čemu je analgezija omogućena bez nuspojava povezanih s toksičnosti spužve kolagena.
14. Uporaba iz patentnih zahtjeva 6-11 pri čemu naprava umanjuje pacijentovu potrebu za sustavnom analgezijom.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE2007/0220A IE85880B1 (en) | 2007-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
| US11/692,337 US20080241243A1 (en) | 2007-03-28 | 2007-03-28 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
| EP08719893.3A EP2139457B1 (en) | 2007-03-28 | 2008-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
| PCT/IE2008/000035 WO2008117268A2 (en) | 2007-03-28 | 2008-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160743T1 true HRP20160743T1 (hr) | 2016-09-23 |
Family
ID=39540798
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160743TT HRP20160743T1 (hr) | 2007-03-28 | 2016-06-27 | Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca |
| HRP20190699TT HRP20190699T1 (hr) | 2007-03-28 | 2019-04-15 | Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190699TT HRP20190699T1 (hr) | 2007-03-28 | 2019-04-15 | Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP2139457B1 (hr) |
| JP (1) | JP5372905B2 (hr) |
| CY (2) | CY1117814T1 (hr) |
| DE (1) | DE202008018583U1 (hr) |
| DK (2) | DK3085363T3 (hr) |
| ES (2) | ES2718542T3 (hr) |
| HR (2) | HRP20160743T1 (hr) |
| HU (2) | HUE043185T2 (hr) |
| IE (1) | IES20080229A2 (hr) |
| LT (1) | LT3085363T (hr) |
| PL (2) | PL3085363T3 (hr) |
| PT (2) | PT3085363T (hr) |
| SI (2) | SI2139457T1 (hr) |
| TR (1) | TR201905174T4 (hr) |
| WO (1) | WO2008117268A2 (hr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47826E1 (en) | 2007-03-28 | 2020-01-28 | Innocoll Pharmaceuticals Limited | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
| IES20090859A2 (en) * | 2008-11-06 | 2010-06-23 | Innocoll Technologies Ltd | Drug delivery implants and processes for their preparation |
| US8858983B2 (en) | 2009-04-30 | 2014-10-14 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
| US8911427B2 (en) | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
| WO2013086015A1 (en) | 2011-12-05 | 2013-06-13 | Incept, Llc | Medical organogel processes and compositions |
| TR201907156T4 (tr) * | 2012-01-09 | 2019-06-21 | Innocoll Pharm Ltd | Modifiye edilmiş bir kolajen. |
| AU2014223993B2 (en) * | 2013-02-28 | 2016-09-08 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid formulations and its compostions |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| RU2561301C1 (ru) * | 2014-10-06 | 2015-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина" | Способ трансфеморальной блокады нервов мочевого пузыря у мелких животных |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| WO2022162640A1 (en) * | 2021-02-01 | 2022-08-04 | Massey University | Post-operative pain management |
| WO2022219179A1 (en) * | 2021-04-15 | 2022-10-20 | Innocoll Pharmaceuticals Limited | Drug-release implant for soft tissue surgery |
| IL310517A (en) * | 2021-07-28 | 2024-03-01 | Innocoll Pharm Ltd | Bupivacaine-collagen drug delivery implant and methods for its preparation and use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4125400C2 (de) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen |
| JPH08143449A (ja) * | 1994-11-17 | 1996-06-04 | Lederle Japan Ltd | 徐放性局所麻酔用注射剤 |
| US7119062B1 (en) * | 2001-02-23 | 2006-10-10 | Neucoll, Inc. | Methods and compositions for improved articular surgery using collagen |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| DK1809329T3 (da) * | 2004-09-17 | 2012-04-02 | Durect Corp | Vedvarende lokalanæstesisammensætning indeholdende saib |
| JP5047797B2 (ja) * | 2004-09-30 | 2012-10-10 | コヴァロン・テクノロジーズ・インコーポレーテッド | 非接着性の弾性ゼラチンマトリックス |
-
2008
- 2008-03-28 EP EP08719893.3A patent/EP2139457B1/en active Active
- 2008-03-28 ES ES16154811T patent/ES2718542T3/es active Active
- 2008-03-28 DK DK16154811.0T patent/DK3085363T3/en active
- 2008-03-28 ES ES08719893.3T patent/ES2582368T3/es active Active
- 2008-03-28 SI SI200831641A patent/SI2139457T1/sl unknown
- 2008-03-28 IE IE20080229A patent/IES20080229A2/en not_active IP Right Cessation
- 2008-03-28 LT LTEP16154811.0T patent/LT3085363T/lt unknown
- 2008-03-28 JP JP2010500426A patent/JP5372905B2/ja active Active
- 2008-03-28 PT PT16154811T patent/PT3085363T/pt unknown
- 2008-03-28 PL PL16154811T patent/PL3085363T3/pl unknown
- 2008-03-28 HU HUE16154811A patent/HUE043185T2/hu unknown
- 2008-03-28 EP EP16154811.0A patent/EP3085363B1/en active Active
- 2008-03-28 PL PL08719893.3T patent/PL2139457T3/pl unknown
- 2008-03-28 TR TR2019/05174T patent/TR201905174T4/tr unknown
- 2008-03-28 SI SI200832058T patent/SI3085363T1/sl unknown
- 2008-03-28 HU HUE08719893A patent/HUE027803T2/en unknown
- 2008-03-28 WO PCT/IE2008/000035 patent/WO2008117268A2/en active Application Filing
- 2008-03-28 DK DK08719893.3T patent/DK2139457T3/en active
- 2008-03-28 DE DE202008018583.1U patent/DE202008018583U1/de not_active Expired - Lifetime
- 2008-03-28 PT PT87198933T patent/PT2139457T/pt unknown
-
2016
- 2016-06-27 HR HRP20160743TT patent/HRP20160743T1/hr unknown
- 2016-07-14 CY CY20161100677T patent/CY1117814T1/el unknown
-
2019
- 2019-04-12 CY CY20191100409T patent/CY1121568T1/el unknown
- 2019-04-15 HR HRP20190699TT patent/HRP20190699T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2139457T1 (sl) | 2016-09-30 |
| JP5372905B2 (ja) | 2013-12-18 |
| ES2718542T3 (es) | 2019-07-02 |
| CY1117814T1 (el) | 2017-05-17 |
| DK2139457T3 (en) | 2016-07-25 |
| SI3085363T1 (sl) | 2019-07-31 |
| IES20080229A2 (en) | 2008-12-24 |
| JP2010522738A (ja) | 2010-07-08 |
| DE202008018583U1 (de) | 2016-03-14 |
| WO2008117268A2 (en) | 2008-10-02 |
| PL3085363T3 (pl) | 2019-08-30 |
| EP2139457B1 (en) | 2016-05-04 |
| HUE043185T2 (hu) | 2019-08-28 |
| HRP20190699T1 (hr) | 2019-07-12 |
| ES2582368T3 (es) | 2016-09-12 |
| LT3085363T (lt) | 2019-06-25 |
| PL2139457T3 (pl) | 2016-11-30 |
| WO2008117268A3 (en) | 2009-03-26 |
| DK3085363T3 (en) | 2019-04-29 |
| EP3085363A1 (en) | 2016-10-26 |
| PT2139457T (pt) | 2016-07-26 |
| CY1121568T1 (el) | 2020-05-29 |
| HUE027803T2 (en) | 2016-10-28 |
| EP3085363B1 (en) | 2019-03-20 |
| EP2139457A2 (en) | 2010-01-06 |
| PT3085363T (pt) | 2019-05-16 |
| TR201905174T4 (tr) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160743T1 (hr) | Naprava za dopremu lijeka za omogućavanje lokalne analgezije, lokalne anestezije ili blokade živca | |
| ES2836184T3 (es) | Formulaciones tópicas de co-enzima Q10 y tratamiento de heridas | |
| ES2272827T3 (es) | Parche terapeutico transdermico con capsaicina y analogos de capsaicina. | |
| BRPI0707235B1 (pt) | formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual | |
| BR0108379A (pt) | Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide | |
| BRPI0512311A (pt) | uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas | |
| JP2010522738A5 (hr) | ||
| EA200900087A1 (ru) | Применение гидрофильной матрицы, содержащей производное полиакриловой кислоты, простой эфир целлюлозы и дезинтегрирующий агент, в производстве медикаментов для лечения заболеваний женских гениталий | |
| BRPI0415649A (pt) | método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica | |
| ES2691319T3 (es) | Composiciones y métodos para aliviar el dolor sin adormecimiento | |
| AU2020293025A1 (en) | Pain relieving method | |
| WO2004037207A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| JP2020055840A (ja) | 麻痺を伴わない疼痛緩和のための組成物および方法 | |
| CN103393714B (zh) | 局麻药止痛延时剂 | |
| Zhao et al. | Anti-arthritic effects of microneedling with bee venom gel | |
| ES2251623T3 (es) | Dispositivo de cuidado de heridas. | |
| Isaza et al. | Drug delivery to captive asian elephants-treating goliath | |
| DeRossi et al. | Use of ketamine or lidocaine or in combination for subarachnoid analgesia in goats | |
| CN101491526A (zh) | 四氢嘧啶在制备治疗关节炎的药物中的应用 | |
| JP2010528040A (ja) | 疼痛管理のための方法 | |
| WO2016063265A2 (pt) | Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos | |
| NZ703464A (en) | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix | |
| Read | Incisional infiltration of local anesthetics and use of wound catheters | |
| ES2920599T3 (es) | Agente para el tratamiento de heridas o quemaduras en la piel | |
| CA2515259A1 (en) | Use of acetylsalicylic acid for the treatment of hemorrhoidal disease |